NDC 62795-1005

BHI Constipation

Dioscorea Villosa Tuber, Sodium Chloride, And Strychnos Nux-vomica Seed

BHI Constipation is a Oral Tablet in the Human Otc Drug category. It is labeled and distributed by Medinatura Inc. The primary component is Dioscorea Villosa Tuber; Sodium Chloride; Strychnos Nux-vomica Seed.

Product ID62795-1005_25f16472-f472-48be-a1f9-d5741bcf2686
NDC62795-1005
Product TypeHuman Otc Drug
Proprietary NameBHI Constipation
Generic NameDioscorea Villosa Tuber, Sodium Chloride, And Strychnos Nux-vomica Seed
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2014-08-30
Marketing CategoryUNAPPROVED HOMEOPATHIC / UNAPPROVED HOMEOPATHIC
Labeler NameMediNatura Inc
Substance NameDIOSCOREA VILLOSA TUBER; SODIUM CHLORIDE; STRYCHNOS NUX-VOMICA SEED
Active Ingredient Strength4 [hp_X]/1; [hp_X]/1; [hp_X]/1
Pharm ClassesAllergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 62795-1005-3

1 BOTTLE in 1 CARTON (62795-1005-3) > 100 TABLET in 1 BOTTLE
Marketing Start Date2014-08-30
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 62795-1005-2 [62795100502]

BHI Constipation TABLET
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Billing UnitEA
Marketing Start Date2014-08-30

Drug Details

Active Ingredients

IngredientStrength
DIOSCOREA VILLOSA TUBER4 [hp_X]/1

OpenFDA Data

SPL SET ID:0365b75b-fee4-4c1d-89ab-c692bdd73f75
Manufacturer
UNII

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.